Kivexa
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AR - Combinations -> J05AR02 - Kivexa
Administration category:
Free
Medicine group:
antiviral
File parts:
abacavir
lamivudine
Brand name:
Kivexa
Standard dosages
| Weight | ROA | Load | Dosage |
|---|---|---|---|
|
ROA: po |
Load: - |
Dosage: 600/300mg 1 dd |
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: po | ||||
|
GFR: 30 - 50 |
Dosage: gebruik wordt niet aanbevolen |
|||
|
GFR: <30 |
Dosage: gebruik wordt niet aanbevolen |
|||
Renal elimination:
abacavir 83%, lamivudine 83%
Dosage:
dependent on kidney function
Renal function-replacement therapy
CAPD: niet toedienen
Hemo dialysis: niet toedienen
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-287585.1
Updated: 06/16/2019 - 20:05
Status: Published